- Home
- TOVX vs TCRT Comparison
TOVX vs TCRT Comparison
Compare TOVX & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- TCRT
- Stock Information
- Founded
- TOVX 2001
- TCRT 1998
- Country
- TOVX United States
- TCRT United States
- Employees
- TOVX N/A
- TCRT N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- TOVX Health Care
- TCRT Health Care
- Exchange
- TOVX Nasdaq
- TCRT Nasdaq
- Market Cap
- TOVX 3.8M
- TCRT 3.8M
- IPO Year
- TOVX 2006
- TCRT N/A
- Fundamental
- Price
- TOVX $0.50
- TCRT $4.99
- Analyst Decision
- TOVX Hold
- TCRT
- Analyst Count
- TOVX 1
- TCRT 0
- Target Price
- TOVX N/A
- TCRT N/A
- AVG Volume (30 Days)
- TOVX 170.1K
- TCRT 48.8K
- Earning Date
- TOVX 08-12-2025
- TCRT 08-13-2025
- Dividend Yield
- TOVX N/A
- TCRT N/A
- EPS Growth
- TOVX N/A
- TCRT N/A
- EPS
- TOVX N/A
- TCRT N/A
- Revenue
- TOVX N/A
- TCRT $11,000.00
- Revenue This Year
- TOVX N/A
- TCRT $5,680,500.00
- Revenue Next Year
- TOVX N/A
- TCRT N/A
- P/E Ratio
- TOVX N/A
- TCRT N/A
- Revenue Growth
- TOVX N/A
- TCRT 83.33
- 52 Week Low
- TOVX $0.40
- TCRT $1.31
- 52 Week High
- TOVX $7.37
- TCRT $6.90
- Technical
- Relative Strength Index (RSI)
- TOVX 45.57
- TCRT 66.12
- Support Level
- TOVX $0.42
- TCRT $4.72
- Resistance Level
- TOVX $0.48
- TCRT $5.24
- Average True Range (ATR)
- TOVX 0.03
- TCRT 0.46
- MACD
- TOVX 0.02
- TCRT -0.02
- Stochastic Oscillator
- TOVX 88.67
- TCRT 66.89
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.